Puducherry, 22 February 2026: Iswarya Hospital, OMR Chennai, a leading center for complex oncological interventions, hosted ISWARYA CANCER CONFERENCE – IC-CON 2026 in Pondicherry today. The one-day conference brought together over 100 doctors from Pondicherry and neighbouring districts of Tamil Nadu to discuss the latest advancements in breast and gynaecological oncology. Prof. Dr. S. Rajasundaram, Director of Iswarya Cancer Centre and CEO of Iswarya Hospital, inaugurated the conference. IC-CON 2026.

IC-CON 2026 aimed to create vital awareness regarding gynaecological malignancies, modern diagnostic methods, and evolving treatment options, empowering the local medical community with knowledge for earlier diagnoses and improved patient outcomes. A key focus of the conference was on Hyperthermic Intraperitoneal Chemotherapy (HIPEC) and Cytoreductive Surgery (CRS).

 “Through this IC-CON 2026 conference, we are sharing insights into life-saving procedures like Cytoreductive Surgery (CRS) and Hyperthermic Intraperitoneal Chemotherapy (HIPEC), which have become the standard of care for locally advanced ovarian cancer and Pseudomyxoma Peritonei.” Said Prof. Dr. S. Rajasundaram, Director of Iswarya Cancer Centre and CEO of Iswarya Hospital.

Iswarya Hospital has gained a reputation for taking on challenging cases, including a recent 10-hour surgery on an international patient with a dangerously low heart function (29% ejection fraction), highlighting the hospital’s multidisciplinary approach to precision care, added Prof Dr S Rajasundaram

“This IC-CON 2026 reflects our commitment to patients who have nowhere else to turn,” said Dr. Arun Muthuvel, Managing Director, Iswarya Hospital “By fostering a culture of continuous learning and sharing our experiences in high-risk surgical care, we reinforce our position as a trusted center for advanced oncology” added Dr Arun Muthuvel

“The conference brought together a multidisciplinary team of health experts, with Dr. Deepa Chegu speaking on improving diagnostic confidence in breast cancer and the role of 3D mammography. Dr. Ruthrendra highlighted HIPEC in gynaecological cancers, while Dr. Varadharajan shared molecular insights from MDT to management and its implications in endometrial cancer. Dr. Rishan discussed precision radiation in gynaecological cancers, Dr. Ramprabhu presented his views on immunotherapy in gynaecological cancers and Dr. Rajasundaram delivered a video session on SLNB and robotic staging for endometrial cancer.

The one-day conference concluded with a panel discussion on interesting and challenging cases in gynaecological oncology.